# KALA BIO, Inc.: Form SCHEDULE 13D, filed Feb 6, 2026

- Company: [KALA BIO, Inc.](/companies/kala.md) (CIK 1479419)
- Form: SCHEDULE 13D
- Filed: 2026-02-06
- Accepted by EDGAR: Feb 6, 2026, 16:14 ET
- Period: not reported
- Accession: 0001829126-26-001059
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001059/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001059/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479419/000182912626001059/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001829126-26-001059. Last ingested by Listed: Nov 3, 2026, 19:22 ET. No prices; not investment advice.